October 28, 2024—Medtronic announced new long-term data from the SPYRAL HTN-ON MED clinical trial of the company’s Symplicity Spyral renal denervation (RDN) system. The findings show that patients who ...

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation ...

and will compare it to an historical control group of patients that have received drug-eluting stents through Medtronic’s prior clinical studies of its Resolute Onyx implant. Participants in ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...

These include stents, catheters and angioplasty balloons; which are used to address concerns such as; narrowed or blocked arteries, varicose veins, or chronic venous insufficiency. Augmenting ...

A newly FDA- approved stent designed to grow with the child offers a better option.Oct. 17, 2024 ...

Medtronic in Santa Ana says its layoffs would be temporary while it repairs the roof of its medical device-making facility, while Avante Health Solutions in San Clemente hopes to retain its staff ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

India’s coronary stent market, valued at Rs 1,300 crore, is expanding at a compound annual growth rate (CAGR) of 12 per cent. Global giants such as Abbott Vascular, Boston Scientific, and Medtronic ...

Finally, Dr. Eagle discusses short-term dual antiplatelet therapy (DAPT) after drug-eluting stenting in patients with acute coronary syndrome (ACS).

Abbott, Boston Scientific, Medtronic, Biotronik, Terumo Corporation, and B. Braun SE are the leading global coronary stents market companies. These vendors are continuously developing and ...